We are live on ! Find out more
BMY icon

Bristol-Myers Squibb
BMY

2,602 hedge funds and large institutions have $116B invested in Bristol-Myers Squibb in 2022 Q4 according to their latest regulatory filings, with 264 funds opening new positions, 1,006 increasing their positions, 966 reducing their positions, and 87 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

0% more capital invested

Capital invested by funds: $116B → $116B (+$71M)

1.73% less ownership

Funds ownership: 77.02% → 75.29% (-1.7%)

33% less funds holding in top 10

Funds holding in top 10: 114 → 76 (-38)

Holders
2,602
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
76
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.26B
Puts
$1.82B
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
+$440M
2
+$274M
3
+$229M
4
Citadel Advisors
Citadel Advisors
Florida
+$215M
5
Norges Bank
Norges Bank
Norway
+$164M

Top Sellers

Rank Fund Capital Flow
1
-$1.84B
2
-$813M
3
-$659M
4
Franklin Resources
Franklin Resources
California
-$449M
5
Bank of America
Bank of America
North Carolina
-$382M
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$14.6B
2
$12.4B
3
$7.1B
4
$6.67B
5
$4.25B
6
$3.79B
7
$2.89B
8
$2.78B
9
$2.55B
10
$1.98B
11
$1.87B
12
$1.78B
13
$1.7B
14
$1.57B
15
$1.34B
16
$1.3B
17
$1.27B
18
$1.19B
19
$1.19B
20
$1.13B
21
$1.08B
22
$992M
23
$851M
24
$806M
25
$803M
1
2 3 4 5

BMY Hedge Fund Activity: Q4 2022 in Review

2,602 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q4 2022, worth a combined $116B — up 0.06% from $116B a quarter earlier.

Buyers outnumbered sellers: 264 funds opened new BMY positions and 87 closed out — a net gain of 177 holders — while 1,006 added to existing stakes and 966 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $440M. The largest seller was Wellington Management Group, cutting an estimated $1.84B.

  • 2,602 institutional investors held Bristol-Myers Squibb (BMY) as of Q4 2022, up from 2,471 in Q3 2022.
  • Funds reported $116B of Bristol-Myers Squibb stock for Q4 2022, up 0.06% quarter-over-quarter.
  • 264 funds opened new Bristol-Myers Squibb positions in Q4 2022 and 87 closed out, a net change of +177 holders.
  • The largest Bristol-Myers Squibb buyer in Q4 2022 was Morgan Stanley, an estimated $440M added.
  • The largest Bristol-Myers Squibb seller in Q4 2022 was Wellington Management Group, an estimated $1.84B sold.

Based on aggregated 13F filings for Q4 2022.